WCI

Home > RI Related News > RI Related News

RI Related News

게시글 목록
No	TItle	Name	Date	Hit
710	Facility for rare Isotope Beams to Open its Doors to Discovery	WCI Secretariat	2022/05/04	751
709	Plus Therapeutics and Medidata Announce Expanded Clinical Trial Partnership	WCI Secretariat	2022/05/04	756
708	Australian Prime Minister Announces Funding for Precision Medicine	WCI Secretariat	2022/05/04	778
707	Clovis Oncology Highlights Presentations On FAP-2286 And Rubraca® (Rucaparib) At The AACR Annual Meeting 2022	WCI Secretariat	2022/05/03	769
706	Fast Electrons Accelerate the Production of Medical Isotopes	WCI Secretariat	2022/05/03	780
705	NorthStar Medical Radioisotopes provides Updates on Corporate progress and Progress and Upcoming Milestones	WCI Secretariat	2022/05/03	794
704	Novartis Pluvicto™ approved by FDA as first targeted radioligand therapy for treatment of progressive, PSMA positive metastatic castration-resistant prostate cancer	WCI Secretariat	2022/04/08	799
703	BOC Sciences Updates Product List to Expand Access to Stable Isotope-Labeled Amino Acids	WCI Secretariat	2022/04/08	844
702	POINT Biopharma Confirms No Delays to SPLASH Trial Due to Recent Global Lutetium Supply Interruption	WCI Secretariat	2022/04/08	847
701	Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials	WCI Secretariat	2022/04/08	844
700	Eckert & Ziegler Extends Supply Agreement with Sirtex Medical to Chinese Market	WCI Secretariat	2022/04/08	839
699	Telix Radiopharmaceutical Production Facility Buildout Commences	WCI Secretariat	2022/04/08	845
698	High Flux Reactor back in full operation	WCI Secretariat	2022/04/08	889
697	Clovis Oncology And Evergreen Theragnostics Initiate Development And Manufacturing Services Agreement For Actinium-225-Labeled FAP-2286	WCI Secretariat	2022/04/08	842
696	Precirix raises EUR 80m in Series B to advance its pipeline of precision radiopharmaceuticals	WCI Secretariat	2022/04/08	872

First Prev 1 2 3 4 5 6 7 8 9 10 Next End (55 Page)

비밀글입니다!

글작성시 입력했던 비밀번호를 입력해주세요.